Role of Adenosine in Response to Vascular Inflammation
Role of Adenosine in Response to Vascular Inflammation
复制标题
DOI:
10.1161/atvbaha.112.247874
复制
发表时间:
2012-04-01
影响因子:
8.7
通讯作者:
Linden, Joel
中科院分区:
文献类型:
--
作者:
Linden, Joel
The first known function of adenosine was as a central factor in the biochemistry of energy production. Perhaps as a result of that role, it also evolved as a signaling molecule that links metabolic stress and tissue damage to the activation of 4 G protein coupled adenosine receptors. An early appreciation of the physiology of adenosine preceded by many decades the discovery of the cell biology of adenosine signaling. The first recognized physiological activity of adenosine was “disturbance of the heart beat” initially described in a remarkably elegant study for the year 1929, conducted at the University of Cambridge by Drury and Szent-Györgyi. 1 This preceded by 34 years the realization, first articulated by Robert Berne, that adenosine is responsible for the “metabolic regulation of coronary blood flow.” 2 Once adenosine receptors were identified in the 1980’s and 1990’s and selective agonists and antagonists became available, rapid progress was made in pinpointing the identity and function of adenosine receptor subtypes on cardiac and vascular tissues. During that time it was also realized that 1 or more adenosine receptors are found on all cell types and their functions are numerous. In recent years the field of adenosine signaling has moved beyond questions of direct cardiovascular effects of adenosine and focused on more complex questions: What are the roles of adenosine in embryonic development and in responses to chronic inflammatory diseases that are often associated with the accumulation of very high tissue levels? The series of reviews in this volume focus on newly appreciated roles of adenosine in embryonic development and vascular pathophysiology. It is notable also that the expression of adenosine receptors on various tissues, and the expression of enzymes that are involved in adenosine production, such as CD73, are not constant, as once thought, but are now known to be highly transcriptionally regulated by certain cytokines, pathogens, and hypoxia. Thus, it is now appreciated that in chronic diseases, both the production of adenosine and the expression of adenosine receptors undergo major changes.In their article about the control of erectile function, Wen and Xia compare and contrast the roles of the major vasodilators, nitric oxide and adenosine, in health and disease. The article serves to illustrate that either overproduction or underproduction of adenosine can produce pathology. The review also serves as a reminder that adenosine remains a key physiological regulator of blood flow, irrespective of the attention focused on nitric oxide as another vasodilator signaling molecule. Adenosine production normally serves to protect stressed tissues from injury, but adenosine overproduction can contribute to pathology as occurs in priapism. Another newly appreciated important effect of adenosine is on embryonic development. Rivkees and Wendler summarize recent findings demonstrating that disruption of adenosine signaling in embryos, particularly during hypoxia, produce changes in cardiac function that persist into adulthood. Interestingly, they also identify caffeine, a widely consumed adenosine receptor antagonist, as possibly dangerous to the fetus. This emphasizes the point that adenosine produced during tissue stress plays a critically important role in engaging processes to protect cells from injury.